Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro comes in a pre-filled injector pen called the KwikPen — a compact, reusable-looking device that's actually single-use, delivering four weekly doses from one pen. If you're trying to picture what you'll be handling before your first prescription, this page walks through the pen's appearance, the injection process, and what to expect each week — all based on the licensed UK product from Eli Lilly. Like all weight-management medicines in this class, Mounjaro is a prescription-only medicine, so treatment starts with a clinical assessment to confirm it's right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is a pre-filled injector roughly the length of a felt-tip marker (around 14–15 cm) with a clear inspection window in the middle so you can see the medicine inside. It's thicker than a standard insulin pen, and it's designed to be held like a dart or pressed flat against the skin depending on the injection technique. A grey needle cap sits at one end; the dose button is at the other.
The body of the pen is white or off-white, and the label wraps around it showing the dose strength. Eli Lilly colour-codes each strength so they're easy to tell apart at a glance: the 2.5mg starter pen, for instance, has a different label band to the 5mg or 10mg versions. When you look through the inspection window before an injection you should see a clear or almost-colourless liquid. Cloudiness, particles or discolouration are reasons to discard the pen and contact your prescriber, the Mounjaro SmPC on the eMC covers this in detail.
One pen holds four weekly doses. There's a dose counter on most versions so you can see how many are left. Each dose is dialled or counted automatically, you don't measure anything yourself.
A question our prescribers hear most weeks is: "will I actually be able to do this myself?" The short answer is that the pen is designed specifically so that most adults can use it without clinical training after reading the instructions once.
The sequence is straightforward. Clean the injection site with an alcohol swab and let it dry. Remove the needle cap. Press the pen against the skin (or pinch the skin slightly if you're injecting the abdomen) then press the dose button and hold it in place for several seconds until the click confirms delivery. The needle is typically 4–5 mm: short enough that most people barely feel it. Remove the pen at a right angle to the skin to avoid dragging.
Rotating injection sites matters. The same spot used repeatedly can become hardened or lumpy (lipohypertrophy), which affects how reliably the medicine absorbs. The three approved sites (abdomen, thigh and upper arm) each have enough surface area to vary position each week. Our practical Mounjaro tips page covers injection technique and site rotation in more detail.
The physical format of the KwikPen is consistent across all six UK strengths, which makes it reassuring when your dose is increased, you're not learning a new device, just handling a differently labelled pen. What changes is the concentration of tirzepatide inside, not the pen's mechanics.
Treatment starts at 2.5mg, a strength that exists to help your body adjust, not as a therapeutic target. The prescriber typically steps the dose up every four weeks, moving through 5mg, 7.5mg and so on, based on how you're tolerating it and how your weight is responding. NICE's appraisal of tirzepatide (TA1026) outlines the clinical framework within which prescribers make those decisions, including the evidence base from large clinical trials. If you're curious about how Mounjaro's mechanism compares with other medicines in the class, the tirzepatide and Mounjaro explained page clarifies the relationship between the two names.
Strength availability matters practically. The best places to get Mounjaro in the UK page discusses why supply can vary and what to look for in a regulated provider, especially relevant when you're mid-titration and need a specific dose.
Used pens contain a retracted needle and must be disposed of as clinical waste, not in household recycling. A sharps container is the correct method. NHS guidance on tirzepatide on the NHS website covers disposal, and pharmacies including those registered with the GPhC can advise on local sharps disposal schemes.
Storage before use is refrigerated: 2–8°C. The pen should not be frozen and should be kept away from the freezer compartment. There is a limited window during which a pen can be kept at room temperature, but that window varies by product version, always check the Patient Information Leaflet rather than relying on a general figure. The pen itself should be kept in its original packaging, away from direct light.
If you're thinking about what the full treatment journey looks like (from the first 2.5mg pen through to a maintenance dose) it's worth reading the Mounjaro treatment overview before your consultation. For anyone weighing up the cost of private treatment, the Mounjaro cost context page explains what UK prices typically include and why the headline figure is rarely the full picture. And if you want to understand how Mounjaro sits alongside newer investigational medicines, the retatrutide versus Mounjaro comparison is a useful read.
When you're ready to find out whether Mounjaro is clinically suitable for you, speak to our prescribers, the consultation is free, and a GPhC-registered clinician reviews every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.